# Clinical Evaluation of the RH210 Hearing Aid

> **NCT07572357** · NA · NOT_YET_RECRUITING · sponsor: **Rehear Audiology Company LTD** · enrollment: 24 (estimated)

## Conditions studied

- Hearing Impairment, Sensorineural
- Perceived Hearing Loss

## Interventions

- **DEVICE:** Investigational device (RH210A)
- **DEVICE:** Apple AirPods Pro (2nd Generation) with Hearing Aid Feature (HAF)

## Key facts

- **NCT ID:** NCT07572357
- **Lead sponsor:** Rehear Audiology Company LTD
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2026-07
- **Final completion:** 2026-08
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-05-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07572357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07572357, "Clinical Evaluation of the RH210 Hearing Aid". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07572357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*